Reduction in excitability of the auditory nerve following electrical stimulation at high stimulus rates: V. Effects of electrode surface area

Short-term overstimulation affects peripheral but not central excitability in an animal model of cochlear implantation

Objective: A smallbut persistent proportion of individuals do not gain the expected benefit from cochlear implants(CI). A step-change in the understanding of factors affecting outcomes could come through data science. This study evaluates clinical data capture to assess the quality and utility of Cl user's health records for data science, by assessing the recording of otitis media. Otitis media was selected as it is associated with the development of sensorineural hearing loss and may affect cochlear implant outcomes.Methods: A retrospective service improvement project ·evaluating the medical records of 594 people with a Cl under the care of the University of Southampton Auditory Implant Service between 2014 and 2020.Results: The clinicalrecords are suitable for data science research. Of the cohort studied 20% of Adults and more than 40% of the paediatric cases have a history of middle ear inflammation.Discussion: Data science has potentialto improve cochlear implant outcomes and improve understanding of the mechanisms underlying poor performance, through retrospective secondary analysis of real-world data.Conclusion: Implant centres and the British Cochlear Implant Group National Hearing Implant Registry are urged to consider the importance of consistently and accurate recording of patient data over time for each Cl user. Data where links to hearing loss have been identified, such as middle ear inflammation, may be particularly valuable in future analyses and to inform clinical trials.

The development of neural stimulators: a review of preclinical safety and efficacy studies

OBJECTIVE

Given the rapid expansion of the field of neural stimulation and the rigorous regulatory approval requirements required before these devices can be applied clinically, it is important that there is clarity around conducting preclinical safety and efficacy studies required for the development of this technology.

APPROACH

The present review examines basic design principles associated with the development of a safe neural stimulator and describes the suite of preclinical safety studies that need to be considered when taking a device to clinical trial.

MAIN RESULTS

Neural stimulators are active implantable devices that provide therapeutic intervention, sensory feedback or improved motor control via electrical stimulation of neural or neuro-muscular tissue in response to trauma or disease. Because of their complexity, regulatory bodies classify these devices in the highest risk category (Class III), and they are therefore required to go through a rigorous regulatory approval process before progressing to market. The successful development of these devices is achieved through close collaboration across disciplines including engineers, scientists and a surgical/clinical team, and the adherence to clear design principles. Preclinical studies form one of several key components in the development pathway from concept to product release of neural stimulators. Importantly, these studies provide iterative feedback in order to optimise the final design of the device. Key components of any preclinical evaluation include: in vitro studies that are focussed on device reliability and include accelerated testing under highly controlled environments; in vivo studies using animal models of the disease or injury in order to assess efficacy and, given an appropriate animal model, the safety of the technology under both passive and electrically active conditions; and human cadaver and ex vivo studies designed to ensure the device's form factor conforms to human anatomy, to optimise the surgical approach and to develop any specialist surgical tooling required.

SIGNIFICANCE

The pipeline from concept to commercialisation of these devices is long and expensive; careful attention to both device design and its preclinical evaluation will have significant impact on the duration and cost associated with taking a device through to commercialisation. Carefully controlled in vitro and in vivo studies together with ex vivo and human cadaver trials are key components of a thorough preclinical evaluation of any new neural stimulator.

Tissue damage thresholds during therapeutic electrical stimulation

OBJECTIVE

Recent initiatives in bioelectronic modulation of the nervous system by the NIH (SPARC), DARPA (ElectRx, SUBNETS) and the GlaxoSmithKline Bioelectronic Medicines effort are ushering in a new era of therapeutic electrical stimulation. These novel therapies are prompting a re-evaluation of established electrical thresholds for stimulation-induced tissue damage.

APPROACH

In this review, we explore what is known and unknown in published literature regarding tissue damage from electrical stimulation.

MAIN RESULTS

For macroelectrodes, the potential for tissue damage is often assessed by comparing the intensity of stimulation, characterized by the charge density and charge per phase of a stimulus pulse, with a damage threshold identified through histological evidence from in vivo experiments as described by the Shannon equation. While the Shannon equation has proved useful in assessing the likely occurrence of tissue damage, the analysis is limited by the experimental parameters of the original studies. Tissue damage is influenced by factors not explicitly incorporated into the Shannon equation, including pulse frequency, duty cycle, current density, and electrode size. Microelectrodes in particular do not follow the charge per phase and charge density co-dependence reflected in the Shannon equation. The relevance of these factors to tissue damage is framed in the context of available reports from modeling and in vivo studies.

SIGNIFICANCE

It is apparent that emerging applications, especially with microelectrodes, will require clinical charge densities that exceed traditional damage thresholds. Experimental data show that stimulation at higher charge densities can be achieved without causing tissue damage, suggesting that safety parameters for microelectrodes might be distinct from those defined for macroelectrodes. However, these increased charge densities may need to be justified by bench, non-clinical or clinical testing to provide evidence of device safety.

Intracochlear electrical stimulation suppresses apoptotic signaling in rat spiral ganglion neurons after deafening in vivo

OBJECTIVE

To establish the intracellular consequences of electrical stimulation to spiral ganglion neurons after deafferentation. Here we use a rat model to determine the effect of both low and high pulse rate acute electrical stimulation on activation of the proapoptotic transcription factor Jun in deafferented spiral ganglion neurons in vivo.

STUDY DESIGN

Experimental animal study.

SETTING

Hearing research laboratories of the University of Iowa Departments of Biology and Otolaryngology.

METHODS

A single electrode was implanted through the round window of kanamycin-deafened rats at either postnatal day 32 (P32, n = 24) or P60 (n = 22) for 4 hours of stimulation (monopolar, biphasic pulses, amplitude twice electrically evoked auditory brainstem response [eABR] threshold) at either 100 or 5000 Hz. Jun phosphorylation was assayed by immunofluorescence to quantitatively assess the effect of electrical stimulation on proapoptotic signaling.

RESULTS

Jun phosphorylation was reliably suppressed by 100 Hz stimuli in deafened cochleae of P32 but not P60 rats. This effect was not significant in the basal cochlear turns. Stimulation frequency may be consequential: 100 Hz was significantly more effective than was 5 kHz stimulation in suppressing phospho-Jun.

CONCLUSIONS

Suppression of Jun phosphorylation occurs in deafferented spiral ganglion neurons after only 4 hours of electrical stimulation. This finding is consistent with the hypothesis that electrical stimulation can decrease spiral ganglion neuron death after deafferentation.

Post stimulus effects of high frequency biphasic electrical current on a fibre's conductibility in isolated frog nerves

OBJECTIVE

High frequency biphasic (HFB) electrical currents are widely used in nerve blocking studies. Their safety margins largely remain unknown and need to be investigated.

APPROACH

This study, exploring the post stimulus effects of HFB electrical currents on a nerve's conductibility, was performed on bullfrog sciatic nerves. Both compound action potentials (CAPs) and differential CAPs (DCAPs, i.e. control CAPs subtracted by CAPs following HFB currents) were obtained, and N1 and N2 components, which were the first and second upward components of DCAPs, were used for analyses of the effects introduced by HFB electrical stimulation.

MAIN RESULTS

First, HFB currents of 10 kHz at a completely blocking threshold were applied for 5 s. The maximum amplitudes and conducting velocities of the CAPs were significantly (P < 0.02) decreased within the observed period (60 s) following HFB currents. The DCAPs displayed clear N1 and N2 components, demonstrating respectively the losses of the fibres' normal conductibility and the appearances of new delayed conductions. Decreases of N1 amplitudes along time, regarded as the recovery of the nerve's conductibility, exhibited two distinct phases: a fast one lasting several seconds and a slow one lasting longer than 5 min. Further tests showed a linear relationship between the HFB stimulation durations and recovering periods of N1 amplitudes. Supra-threshold blocking did not cause higher N1 amplitudes.

SIGNIFICANCE

This study indicates that HFB electrical currents lead to long lasting post stimulus reduction of a nerve's conductibility, which might relate to potential nerve injuries. A possible mechanism, focusing on changes in intracellular and periaxonal ionic concentrations, was proposed to underlie the reduction of the nerve's conductibility and potential nerve injuries. Greater caution and stimulation protocols with greater safety margins should be explored when utilizing HFB electrical current to block nerve conductions.

Continuous electrical stimulation decreases retinal excitability but does not alter retinal morphology

Retinal prostheses aim to provide visual perception through electrical stimulation of the retina. Hence they have to operate between threshold charge density and maximum safe charge density. To date most studies in the retina have concentrated on understanding the threshold, while stimulation safety has predominantly been studied in structures other than the retina. Toward this end, the present study focuses on determining the effect of continuous electrical stimulation of the retina both on retinal morphology and on the electrically evoked responses in the superior colliculus in a rodent model. The results demonstrate that the retina is able to tolerate 1 h long stimulation with only minor changes evident in retinal histology when examined three to 14 days later, even at charge densities (0.68 mC cm(-2)) above the safe limit of platinum delivered at high stimulus frequency (300 Hz). However, this continuous electrical stimulation causes an elevation in the threshold of the electrically evoked response in the superior colliculus, indicating some form of adaptation to continuous stimulation.

Retinal prostheses: current challenges and future outlook

Blindness from retinal diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP), usually causes a significant decline in quality of life for affected patients. Currently there is no cure for these conditions. However, over the last decade, several groups have been developing retinal prostheses which hopefully will provide some degree of improved visual function to these patients. Several such devices are now in clinical trials. Unfortunately, the possibility of electrode or tissue damage limits excitation schemes to those that may be employed with electrodes that have relatively low charge densities. Further, the excitation thresholds that have been required to achieve vision to date, in general, are relatively high. This may result in part from poor apposition between neurons and the stimulating electrodes and is confounded by the effects of the photoreceptor loss, which initiates other pathology in the surviving retinal tissue. The combination of these and other factors imposes a restriction on the pixel density that can be used for devices that actively deliver electrical stimulation to the retina. The resultant use of devices with relatively low pixel densities presumably will limit the degree of visual resolution that can be obtained with these devices. Further increases in pixel density, and therefore increased visual acuity, will necessitate either improved electrode-tissue biocompatibility or lower stimulation thresholds. To meet this challenge, innovations in materials and devices have been proposed. Here, we review the types of retinal prostheses investigated, the extent of their current biocompatibility and future improvements designed to surmount these limitations.

Binaural interactions of electrically and acoustically evoked responses recorded from the inferior colliculus of guinea pigs

Binaural interactions within the inferior colliculus (IC) elicited by electric and acoustic stimuli were investigated in this study. Using a guinea pig model, binaural acoustic stimuli were presented with different time delays, as were combinations of binaural electric and acoustic stimuli. Averaged evoked potentials were measured using electrodes inserted into the central nucleus of the IC to obtain the binaural interaction component (BIC), computed by subtracting the sum of the two monaural responses from the binaural response. The BICs to acoustic-acoustic stimulation and electric-acoustic stimulation were found to be similar. The BIC amplitude increased with stimulus intensity, but the shapes of the delay functions were similar across the levels tested. The gross-potential data are thus consistent with the thesis that the central auditory system processes binaural electric and acoustic stimuli in a similar manner. These results suggest that the binaural auditory system can process combinations of electric and acoustic stimulation presented across ears and that evoked gross potentials may be used to measure such interaction.

Changes of Postoperative Impedances in Cochlear Implant Patients

OBJECTIVE

The objective of this study was to investigate the effect of intraoperative application of steroid suspension and coating of the electrode contacts with a thin film of iridium oxide on the short-term, time-dependent development of the intracochlear impedance in adults implanted with the Nucleus 24 Contour electrode.

STUDY DESIGN

The time-dependent development of intracochlear impedances was investigated in four different groups of adult patients at daily and later weekly intervals until the first fitting. The four groups were as follows: 1) standard Nucleus 24 Contour (control, n = 7); 2) standard Nucleus 24 Contour with intraoperative application of steroids (Group S, n = 6); 3) iridium-coated Nucleus 24 Contour control (Group I, n = 8); and 4) iridium-coated Nucleus 24 Contour with intraoperative application of steroids (Group I + S, n = 5). All patients had postlinguistic onset of severe to profound sensorineural hearing loss and no or little benefit of conventional hearing aids. Absence of ossification or any other cochlear anomaly and also absence of signs of retrocochlear or central origin to the hearing impairment bilaterally had to be confirmed preoperatively.

RESULTS

Steroid application reduced impedances significantly (Groups S and I + S), whereas iridium coating lowered variance of the impedance among patients but did not reduce the impedance significantly. The steroid-induced reduction is more pronounced at basal electrode contacts. Furthermore, there is some indication that the tissue growth could be faster in patients having the iridium-coated Contour electrode.

CONCLUSION

Provided that the reduction of electrode impedances with application of steroids is persisting, intracochlear application of steroids can be considered on a regular basis. Iridium coating of the electrode contacts seems not to be justified to be included as standard procedure.

A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion

We have developed a novel scala tympani electrode array suitable for use in experimental animals. A unique feature of this array is its ability to chronically deliver pharmacological agents to the scala tympani. The design of the electrode array is described in detail. Experimental studies performed in guinea pigs confirm that this array can successfully deliver various drugs to the cochlea while chronically stimulating the auditory nerve.